Filing Flows › Comparisons › BIO vs TXG
Bio-Rad Laboratories vs 10x Genomics: BIO and TXG compared
Bio-Rad Laboratories is the larger company: $656M of revenue in its latest quarter (Q3 2026) against $151M for 10x Genomics (Q3 2026). 10x Genomics is growing faster (+1% against +0.5% a year earlier). Bio-Rad Laboratories is more profitable, with an operating margin of -7.6% against -10.7%.
Where the money goes: BIO and TXG
Bio-Rad Laboratories (BIO) · Q3 2026
Bio-Rad Laboratories, Q3 2026: revenue $656M (+0.5% year over year), operating margin -7.6%, net earnings $459M, operating cash flow $96.4M. The chart follows the revenue to costs, profit and cash.
10x Genomics (TXG) · Q3 2026
10x Genomics, Q3 2026: revenue $151M (+1% year over year), operating margin -10.7%, net loss $19.4M, operating cash flow $15.8M. The chart follows the revenue to costs, profit and cash.
| Bio-Rad Laboratories (BIO) | 10x Genomics (TXG) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $656M | $151M |
| Revenue growth, Y/Y | +0.5% | +1% |
| Operating margin | -7.6% | -10.7% |
| Net earnings | $459M | −$19.4M |
| Net margin | 69.9% | -12.9% |
| Operating cash flow | $96.4M | $15.8M |
| Free cash flow | $65.2M | $14.9M |
| Market value | $10.3B | — |
| P/E | 10.1× | — |
| Analysts’ mean target | $335.00 | — |
Where the revenue comes from
Bio-Rad Laboratories
- Clinical Diagnostics: $402M (61%)
- Life Science: $255M (39%)
10x Genomics
- Consumables: $134M (89%)
- Services: $9.0M (6%)
- Instruments: $6.9M (5%)
Questions
Which is bigger, Bio-Rad Laboratories or 10x Genomics?
Bio-Rad Laboratories is the larger company: $656M of revenue in its latest quarter (Q3 2026) against $151M for 10x Genomics (Q3 2026).
Is Bio-Rad Laboratories or 10x Genomics growing faster?
10x Genomics is growing faster (+1% against +0.5% a year earlier).
Which is more profitable, Bio-Rad Laboratories or 10x Genomics?
Bio-Rad Laboratories is more profitable, with an operating margin of -7.6% against -10.7%.
More: Bio-Rad Laboratories earnings · how Bio-Rad Laboratories makes money · 10x Genomics earnings · how 10x Genomics makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 4, 2026; 10-Q filed Nov 6, 2026). Fiscal quarters can end on different dates. Not investment advice.